TTrialPathMatch Me to Trials
← Back to trials
RecruitingAutoimmune HepatitisPrimary Sclerosing Cholangitis

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Eligible age

All ages

Accepts

All genders

Locations

7 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and participation in an improvement collaborative. Pediatric Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC), represent a spectrum of AILD which present unique diagnostic and therapeutic challenges.A lack of accepted guidelines for disease monitoring or symptom management results in wide treatment variation with liver transplants indicated in refractory, progressive disease. The aims of A-LiNK are to: 1.) Create a learning health network focused on patient-centered outcomes research characterized by transparent sharing among centers, common priorities, and feasible plans for implementing new practices; 2) shift from traditional investigator-driven study to a patient and family-centered approach, and 3.) improve clinical outcomes and quality of life for pediatric AILD patients.

Sponsor: Children's Hospital Medical Center, Cincinnati

You may qualify if…

  • Clinical diagnosis of autoimmune hepatitis (AIH)
  • Clinical diagnosis of primary sclerosing cholangitis (PSC)
  • Clinical diagnosis of autoimmune sclerosing cholangitis (ASC)

You may not qualify if…

  • History of liver transplant

Where it's recruiting

California

Palo Alto

Indiana

Indianapolis

Missouri

St Louis

Ohio

Cincinnati · Columbus

Pennsylvania

Pittsburgh

Texas

Dallas

Washington

Seattle

Source: ClinicalTrials.gov · NCT05750498 · last updated 2025-07-24

A-LiNK: Improving Outcomes in Autoimmune Liver Disease · TrialPath